Structure-activity relationship studies and biological properties evaluation of peptidic NRP-1 ligands: Investigation of N-terminal cysteine importance

被引:3
|
作者
Puszko, Anna K. [1 ]
Sosnowski, Piotr [2 ,3 ]
Hermine, Olivier [4 ,5 ]
Hopfgartner, Gerard [2 ]
Lepelletier, Yves [4 ,5 ]
Misicka, Aleksandra [1 ]
机构
[1] Univ Warsaw, Fac Chem, Pasteura 1, PL-02093 Warsaw, Poland
[2] Univ Geneva, Dept Inorgan & Analyt Chem, 24 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland
[3] Med Univ Lublin, Dept Bioanalyt, Jaczewskiego 8b, PL-20090 Lublin, Poland
[4] Univ Paris Cite, Imagine Inst, 24 Blvd Montparnasse, F-75015 Paris, France
[5] Lab Cellular & Mol Basis Normal Hematopoiesis & He, INSERM UMR 1163, 24 Blvd Montparnasse, F-75015 Paris, France
关键词
Neuropilin-1; VEGF-A(165); VEGF-A(165)/NRP-1 complex; Protein-ligand interaction; Peptide ligands; ENDOTHELIAL GROWTH-FACTOR; SMALL CYCLIC PEPTIDE; END-RULE PEPTIDES; IN-VITRO; FACTOR BINDING; TARGETING NEUROPILIN-1; ANTITUMOR-ACTIVITY; TUMOR-CELLS; INHIBITORS; ANGIOGENESIS;
D O I
10.1016/j.bmc.2023.117482
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neuropilin-1 (NRP-1) is a major co-receptor of vascular endothelial growth factor receptor-2 (VEGFR-2). It may also stimulate tumour growth and metastasis independently of VEGF-A(165). These functions make VEGF-A(165)/ NRP-1 complex formation and its inhibition of great interest, where NRP-1 is the target for which effective li-gands are sought. Design of peptide-like inhibitors represent a strategy with great potential in the treatment of NRP-1-related disorders. Here, we present the synthesis, molecular modelling, structure-activity relationship studies as well as biological evaluation of peptides with the branched sequences H2N-X-Lys(hArg)-Dab-Oic-Arg-OH and H2N-Lys(X-hArg)-Dab-Oic-Arg-OH. Two of the designed peptides, in which Cys was inserted in X posi-tion, expressed high affinity (similar to 40 nM value) for NRP-1 and were resistant to enzymatic digestion in human serum. Moreover, peptide/NRP-1 complex promoted fast intracytoplasmic protein trafficking towards the plasma membrane in breast cancer cells. Our results suggest that these compounds might be good candidates for further development of VEGF-A(165)/NRP-1 inhibitors.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Developing of pharmacophore and three-dimensional structure-activity relationship models of VCP/p97 ligands and their synthesis and biological evaluation
    Chen, Qinghua
    Wang, Xueyuan
    Ding, Jianjun
    Pan, Yupeng
    Wen, Tiantian
    Lei, Haoyan
    Zhao, Bo
    Zhu, Yongqiang
    JOURNAL OF MOLECULAR STRUCTURE, 2024, 1318
  • [42] Design of non-cysteine-containing antimicrobial β-hairpins:: Structure-activity relationship studies with linear protegrin-1 analogues
    Lai, JR
    Huck, BR
    Weisblum, B
    Gellman, SH
    BIOCHEMISTRY, 2002, 41 (42) : 12835 - 12842
  • [43] Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist
    Calo', G
    Guerrini, R
    Bigoni, R
    Rizzi, A
    Bianchi, C
    Regoli, D
    Salvadori, S
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) : 3360 - 3366
  • [44] Synthesis, evaluation and structure-activity relationship studies of pterodontic acid acylated derivatives with anti-flu A virus (H1N1) activity in vitro
    Huang, Banglian
    Lei, Feifei
    Yu, Haofei
    Chen, Xinglong
    Hu, Weiyan
    Hou, Bo
    Zhang, Rongping
    FITOTERAPIA, 2024, 177
  • [45] Novel pyrazolo[1,5-a]pyridines as orally active EP1 receptor antagonists: Synthesis, structure-activity relationship studies, and biological evaluation
    Umei, Kentaro
    Nishigaya, Yosuke
    Kondo, Atsushi
    Tatani, Kazuya
    Tanaka, Nobuyuki
    Kohno, Yasushi
    Seto, Shigeki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (09) : 2635 - 2642
  • [46] SITE-DIRECTED MUTATIONS THAT ALTER THE INHIBITORY ACTIVITY OF THE TISSUE INHIBITOR OF METALLOPROTEINASES-1 - IMPORTANCE OF THE N-TERMINAL REGION BETWEEN CYSTEINE-3 AND CYSTEINE-13
    OSHEA, M
    WILLENBROCK, F
    WILLIAMSON, RA
    COCKETT, MI
    FREEDMAN, RB
    REYNOLDS, JJ
    DOCHERTY, AJP
    MURPHY, G
    BIOCHEMISTRY, 1992, 31 (42) : 10146 - 10152
  • [47] Quantitative structure-activity relationship studies on antituberculotic N1-cyclopropylquinolones using Szeged Index (Sz)
    Agrawal, VK
    Bano, S
    Mathur, KC
    Khadikar, PV
    INDIAN JOURNAL OF CHEMISTRY SECTION A-INORGANIC BIO-INORGANIC PHYSICAL THEORETICAL & ANALYTICAL CHEMISTRY, 1999, 38 (12): : 1203 - 1208
  • [48] Design, Synthesis, and Structure-Activity Relationship of Substrate Competitive, Selective, and in Vivo Active Triazole and Thiadiazole Inhibitors of the c-Jun N-Terminal Kinase
    De, Surya K.
    Stebbins, John L.
    Chen, Li-Hsing
    Riel-Mehan, Megan
    Machleidt, Thomas
    Dahl, Russell
    Yuan, Hongbin
    Embadi, Aras
    Barile, Elisa
    Chen, Vida
    Murphy, Ria
    Pellecchia, Maurizio
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (07) : 1943 - 1952
  • [49] Synthesis, structure-activity relationship, and biological studies of indolocarbazoles as potent cyclin D1-CDK4 inhibitors
    Zhu, GX
    Conner, SE
    Zhou, X
    Shih, C
    Li, TC
    Anderson, BD
    Brooks, HB
    Campbell, RM
    Considine, E
    Dempsey, JA
    Faul, MM
    Ogg, C
    Patel, B
    Schultz, RM
    Spencer, CD
    Teicher, B
    Watkins, SA
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (11) : 2027 - 2030
  • [50] Structure-activity relationship study at the 3′-N-position of paclitaxel:: Synthesis and biological evaluation of 3′-N-acyl-paclitaxel analogues
    Roh, EJ
    Kim, D
    Lee, CO
    Choi, SU
    Song, CE
    BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (10) : 3145 - 3151